NEW YORK (GenomeWeb News) – Sequenom has appointed Kenneth Buechler and David Pendarvis to its board of directors. Buechler previously was president, CSO, and co-founder of Biosite. Pendarvis is senior VP of organizational development, global general counsel, and secretary of ResMed.
Robert Langer has been named to Millipore's board of directors, where he will take the place of exiting director Daniel Bellus. Langer is the David H. Koch Institute Professor at the Massachusetts Institute of Technology, where he runs the Langer Lab. He also serves on the Board of MIT's McGovern Institute and Whitehead Institute.
Mirna Therapeutics, a developer of microRNA therapeutics, said that it has added three outside directors to its board. Joining the board are Chris Earl, an entrepreneur and investor; Corey Goodman, managing director of venture capital firm VenBio and co-founder of Exelixis; and Evan Melrose, founder and managing director of healthcare venture capital company PTV Sciences.
Simulations Plus has appointed Robert Clark to the position of director of life sciences. He replaces John Crison, who resigned in late October. Clark was previously vice president of science and research at Tripos. He holds a PhD from Cornell University in biochemistry, statistics, and biometry.
The board of directors of BioNanomatrix has tapped Edward Erickson to take over as CEO and president of the company. Erickson, who was executive chairman of the board, takes over the posts from Michael Boyce-Jacino. Tracey Warren, general partner at Battelle Ventures, will succeed Erickson as chairperson. Erickson has served as a director at BioTrove and at Barrier Therapeutics.
Stephen Liggett has been named dean for interdisciplinary research at the University of Maryland School of Medicine. Liggett, a professor of medicine and physiology, will retain his position as director of the Cardiopulmonary Genomics Program at the School of Medicine.
Caris Diagnostics has named Jonathan Knowles to serve as vice chairman of its board of directors. Knowles has formerly served as a board member at Genentech and Chugai.
Regis Technologies has named four new members to its scientific staff, all former employees at DeCode Genetics. The appointments include Nelson Zhao, Igor Likhotvorik, Sied Zegar, and Dragan Ristic, all of which are from DeCode's development and production staff.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.